Efficient large scale stereoinversion of (R)-ethyl 3-hydroxybutyrate

Tetrahedron Asymmetry

Volumn 15, Issue 5, 2004, Pages 821-825

  Carnell, Andrew J ^a   Head, Robert ^b   Bassett, Derek ^b   Schneider, Michael ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Innospec Limited   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPOLYMER; CALCIUM CARBONATE; ETHYL 3 HYDROXYBUTYRATE; HYDROXYBUTYRIC ACID; MESYLIC ACID ETHYL ESTER; POLY(HYDROXYBUTYRATE); UNCLASSIFIED DRUG; WATER;

ADDITION REACTION; ARTICLE; CHEMICAL MODIFICATION; ENANTIOMER; PRIORITY JOURNAL; PRODUCTIVITY; QUANTUM YIELD; STEREOCHEMISTRY; STEREOINVERSION;

EID: 1442350708     PISSN: 09574166     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetasy.2003.12.005     Document Type: Article

References (26)

1. Tschaen, D. M.; Lynch, J. E.; Laswell, W. L.; Volante, R. P.; Shinkai, I. Merck and Co., Inc. (U.S.A.), EP 98-200609.
2. Nakai, T.; Chiba, T. Fujisawa Pharmaceutical Co., Ltd., EP 171064, 1986.
3. Seebach D.Z., Züger M. Helv. Chim. Acta. 65:1982;495.
4. Seebach D.Z., Beck A.K., Breitschuh R., Job K. Org. Synth. 71:1993;39.
5. Eur. Patents EP 0043620 and EP 0320046.
6. Fräter G. Helv. Chim. Acta. 62:1979;2825.
7. Seebach D.Z., Züger M.F. Tetrahedron Lett. 25:1985;2747.
8. Kramer A., Pfanler H. Helv. Chim. Acta. 65:1982;293.
9. Seebach D., Roggo S., Zimmermann J. Bartmann W., Sharpless K.B. Stereochemistry of Organic and Bioorganic Transformations. Proceedings of the Seventh Workshop Conference Hoechst, Weinheim, New York. 1986,1987;Verlag Chemie.
10. Burk M.J., Feaster J.E., Harlow R.L. Tetrahedron: Asymmetry. 2:1991;569.
11. Burk, M. J.; du Pont de Nemours, I. I., et al. WO 9219630.
12. Seebach D., Sutter M.A., Weber R.H., Züger M.F. Org. Synth. Coll. Vol. VII. 1990;215.
13. Fiechter, A.; Rohner, M.; Sonnleitner, B. Schweizerische Eidenossenschaft, CH 675882, 1990.
14. Kometani, T.; Fujimori, Y.; Daito Koeki, K. K. EP 400239, 1990.
15. Lafferty R.M., Braunegg G., Korneti L., Strmpfl F., Bogensberger B., Karsatko W., Wabnegg B. Eur. Congr. Biotechnol. 3rd vol. 1:1984;Verlag Chemie.
16. Kimura H., Yoshida D.Y. Biotechnol. Lett. 14:1992;445.
17. Blacker A.J., Holt R.A. Development of a Multi-Stage Chemical and Biological Process for an Optically Active Intermediate for an Anti-Glaucoma Drug. Collins A.N., Sheldrake G.N., Crosby J. Chirality in Industry II. 1997;John Wiley.
18. Kitamura M., Tokunaga M., Ohkuma T., Noyori R. Org. Synth. 71:1990;1.
19. Griesbeck A., Seebach D. Helv. Chim. Acta. 70:1987;1320.
20. For details of the methyl ester tosylate, see: Blacklock T.J., Sohar P., Butcher J.W., Lamanec T., Grabowski E.J.J. J. Org. Chem. 58:1993;1672.
21. Cainelli G., Manescalchi F., Martelli G., Panunzio M., Plessi L. Tetrahedron Lett. 26:1985;3369.
22. Burkard U., Effenberger F. Chem. Ber. 119:1986;1594.
23. Danda H., Furukawa Y., Umemura T. Synlett. 1991;441.
24. Danda H., Nagatomi T., Maehara A., Umemura T. Tetrahedron. 47:1991;8701.
25. Sawamura M., Kuwano R., Shirai J., Ito Y. Synlett. 1995;347.
26. Dakoji S., Shin I., Battaile K.P., Vockley J., Liu H.-W. Bioorg. Med. Chem. 1997;2157.